Bendamustine as first-line treatment in patients with advanced indolent non-Hodgkin lymphoma and mantle cell lymphoma in German routine clinical practice
Becker, M., Tschechne, B., Reeb, M., Schwinger, U., Bruch, H.-R., Frank, M., Straßl, L.
Published in Annals of hematology (01.09.2015)
Published in Annals of hematology (01.09.2015)
Get full text
Journal Article
Androstenedione metabolism in cultured human osteoblast-like cells
Bruch, H R, Wolf, L, Budde, R, Romalo, G, Schweikert, H U
Published in The journal of clinical endocrinology and metabolism (01.07.1992)
Published in The journal of clinical endocrinology and metabolism (01.07.1992)
Get more information
Journal Article
454 PREDICTIVE FACTORS OF THROMBOCYTOPENIA IN TREATMENT OF CHRONIC HEPATITIS C (CHC) PATIENTS WITH PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN
Mauss, S, Schober, A, Lutz, T, Moog, G, Schuchmann, M, Heyne, R, John, C, Schiffelholz, W, Baumgarten, A, Hey, K.-H, Eisenbach, C, Teuber, G, Schmidt, W, Bruch, H.-R, Geyer, P, Alshuth, U, Hueppe, D
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
Treatment of chronic hepatitis B with interferon alpha-2b and interleukin-2
Bruch, H R, Korn, A, Klein, H, Markus, R, Malmus, K, Baumgarten, R, Müller, R
Published in Journal of hepatology (1993)
Published in Journal of hepatology (1993)
Get full text
Journal Article
98P Final results from AVANTI, a multicentre German observational study of first-line bevacizumab (BEV) + chemotherapy (CT) in >2000 patients (pts) with advanced breast cancer (aBC)
Mueller, V., Ruhnke, M., Hoffmann, O., Grafe, A., Tomé, O., Fett, W., Bruch, H-R., Sommer, A-K., Schneeweiss, A.
Published in Annals of oncology (01.05.2021)
Published in Annals of oncology (01.05.2021)
Get full text
Journal Article
1500P - Patients with metastatic non-small cell lung cancer without molecular alterations or PD-L1 expression in Germany: Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315)
Griesinger, F., Eberhardt, W.E.E., Bruch, H.-R., Rauh, J., von der Heyde, E., Marschner, N.W., Jänicke, M., Fleitz, A., Spring, L., Sahlmann, J., Karatas, A., Hipper, A., Weichert, W., Sadjadian, P., Metzenmacher, M., Gleiber, W., Sebastian, M., Thomas, M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Patients with metastatic non-small cell lung cancer without molecular alterations or PD-L1 expression in Germany: Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315)
Griesinger, F., Eberhardt, W.E.E., Bruch, H.-R., Rauh, J., von der Heyde, E., Marschner, N.W., Jänicke, M., Fleitz, A., Spring, L., Sahlmann, J., Karatas, A., Hipper, A., Weichert, W., Sadjadian, P., Metzenmacher, M., Gleiber, W., Sebastian, M., Thomas, M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Abstract P1-11-01: Effectiveness, safety and quality of life (QoL) results from the German multicenter AVANTI study of 1st-line bevacizumab (BEV)-containing therapy in >2000 patients (pts) with advanced breast cancer (aBC)
Müller, V, Jakob, A, Aktas, B, Grafe, A, März, W, Fett, W, Bruch, H-R, Klare, P, Hoefflin, S, Schneeweiss, A
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
409P Causes of mortality in elderly UICC stage III colon cancer (CC) patients (pts.) - Tumor related death and competing risks from the Colopredict Plus (CPP) registry
Nöpel-Dünnebacke, S., Klaassen-Mielke, R., Feder, I.S., Kraeft, A-L., Teschendorf, C., Collette, D., Böhner, H., Engel, L., Müller, L., Hartmann, F., Kaiser, U., Bruch, H-R., Giagounidis, A., Graeven, U., Hollerbach, S., Arnold, D., Timmesfeld, N., Reinacher-Schick, A., Tannapfel, A.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Abstract P6-13-02: Efficacy of first-line bevacizumab (BEV)-containing therapy for poor-prognosis advanced breast cancer (aBC): Subgroup analyses of the German AVANTI observational study
Mueller, V, Jakob, A, Aktas, B, Pott, D, Grafe, A, Jungberg, P, Maerz, W, Fett, W, Bruch, H-R, Klare, P, Boller, E, Hoefflin, S, Schneeweiss, A
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
1500PPatients with metastatic non-small cell lung cancer without molecular alterations or PD-L1 expression in Germany: Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315)
Griesinger, F, Eberhardt, W E E, Bruch, H-R, Rauh, J, von der Heyde, E, Marschner, N W, Jänicke, M, Fleitz, A, Spring, L, Sahlmann, J, Karatas, A, Hipper, A, Weichert, W, Sadjadian, P, Metzenmacher, M, Gleiber, W, Sebastian, M, Thomas, M
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Treatment of chronic hepatitis B with interferon α-2b and interleukin-2
Bruch, H.R., Korn, A., Klein, H., Markus, R., Malmus, K., Baumgarten, R., Müller, R.
Published in Journal of hepatology (1993)
Published in Journal of hepatology (1993)
Get full text
Journal Article
Conference Proceeding
Physiologic diagnosis of subclinical emphysema
Gelb, A F, Gold, W M, Wright, R R, Bruch, H R, Nadel, J A
Published in The American review of respiratory disease (01.01.1973)
Get more information
Published in The American review of respiratory disease (01.01.1973)
Journal Article
Cross-activity of various established antineoplastic regimens in primary breast cancer cells evaluated by the ex vivo ATP tumor chemosensitivity assay
Nagel, W. J., Luecke, J., Cree, I. A., Reinhold, U., Kurbacher, J. A., Reichelt, R., Bruch, H. R., Kurbacher, C. M.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Epidemiologie, Behandlungsergebnisse und Kosten der Behandlung chronischer HCV-Patienten in Deutschland – Ergebnisse einer großen Multicenter Studie
Rossol, S, Stahmeyer, JT, Bert, F, Mauss, S, Link, R, Boeker, KHW, Lutz, T, John, C, Schober, A, Stoehr, A, Heyne, R, Bruch, HR, Baumgarten, A, Moeller, B, Hueppe, D, Zehnter, E, Pfeiffer-Vornkahl, H, Alshuth, U, Krauth, C
Published in Zeitschrift für Gastroenterologie (16.08.2013)
Published in Zeitschrift für Gastroenterologie (16.08.2013)
Get full text
Conference Proceeding
Starke Assoziation von Markern des metabolischen Syndroms mit HCV Genotyp1,4,5 und schlechteres Therapieansprechen bei Patienten mit gestörter Glukosetoleranz
Jaeckel, E, Zehnter, E, Lutz, T, Carlebach, A, Link, R, John, C, Teuber, G, Schmidt, W, Bruch, HR, Heyne, R, Geyer, P, Weber, B, Stern, M, Naumann, U, Spengler, U, Herold, C, Stoehr, A, Sandow, P, Stoll, S, Manns, MP
Published in Zeitschrift für Gastroenterologie (22.08.2012)
Published in Zeitschrift für Gastroenterologie (22.08.2012)
Get full text
Conference Proceeding
Pathologischer Glukosestoffwechsel und therapierter Hypertonus identifizieren HCV-Patienten mit negativen prognostischen Parametern für das Erreichen einer SVR
Jaeckel, E, Zehnter, E, Lutz, T, Carlebach, A, Link, R, John, C, Hey, KH, Teuber, G, Schmidt, W, Bruch, HR, Heyne, R, Geyer, P, Weber, B, Stern, M, Naumann, U, Spengler, U, Herold, C, Stoehr, A, Sandow, P, Stoll, S, Manns, MP
Published in Zeitschrift für Gastroenterologie (09.08.2011)
Published in Zeitschrift für Gastroenterologie (09.08.2011)
Get full text
Conference Proceeding